Hans Gelderblom

Hans Gelderblom

UNVERIFIED PROFILE

Are you Hans Gelderblom?   Register this Author

Register author
Hans Gelderblom

Hans Gelderblom

Publications by authors named "Hans Gelderblom"

Are you Hans Gelderblom?   Register this Author

100Publications

2701Reads

15Profile Views

Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors.

Pharmacogenomics J 2019 Oct 4;19(5):473-479. Epub 2019 Feb 4.

Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41397-019-0079-zDOI Listing
October 2019

Stromal organization as predictive biomarker for the treatment of colon cancer with adjuvant bevacizumab; a post-hoc analysis of the AVANT trial.

Cell Oncol (Dordr) 2019 Oct 17;42(5):717-725. Epub 2019 May 17.

Department of Surgery, Leiden University Medical Centre, Albinusdreef 2, 2300 RC, Leiden, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13402-019-00449-9DOI Listing
October 2019

Reply to C.L. Braal et al, H. Brauch et al, and M.P. Goetz et al.

J Clin Oncol 2019 Aug 18;37(22):1984-1985. Epub 2019 Jun 18.

Henk-Jan Guchelaar, PharmD, PhD and Anabel Sanchez-Spitman, PharmD, Leiden University Medical Center, Leiden, the Netherlands; Vincent Dezentjé, MD, PhD, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Stefan Böhringer, PhD, MD and Jesse Swen, PharmD, PhD, Leiden University Medical Center, Leiden, the Netherlands; Patrick Neven, MD, PhD, University Hospitals Leuven, Leuven, Belgium; and Hans Gelderblom, MD, PhD, Leiden University Medical Center, Leiden, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.00932DOI Listing
August 2019

Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial.

Oncologist 2019 Jul 30;24(7):889-e421. Epub 2019 Apr 30.

Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0280DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656477PMC
July 2019

The effect of gastrectomy on regorafenib exposure and progression-free survival in patients with advanced gastrointestinal stromal tumours.

Br J Clin Pharmacol 2019 Jul 10. Epub 2019 Jul 10.

Department of pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.14061DOI Listing
July 2019

A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy.

Eur J Cancer 2019 Jan 11;107:60-67. Epub 2018 Dec 11.

Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183147
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.11.010DOI Listing
January 2019

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.

Lancet Oncol 2018 11 19;19(11):1459-1467. Epub 2018 Oct 19.

Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, Netherlands. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045183068
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(18)30686-7DOI Listing
November 2018

Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events.

Eur J Cancer 2018 Nov 24;104:182-187. Epub 2018 Oct 24.

Department of Thoracic Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183138
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.09.012DOI Listing
November 2018

Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD Variants.

Genes (Basel) 2018 Nov 28;9(12). Epub 2018 Nov 28.

Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/genes9120585DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316498PMC
November 2018

High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008.

J Clin Oncol 2018 Sep 6:JCO2018782516. Epub 2018 Sep 6.

Jeremy Whelan, University College Hospital; Ian Judson, Institute of Cancer Research, London; Bernadette Brennan, Royal Manchester Children's Hospital, Manchester; Bruce Morland, Birmingham Children's Hospital; Keith Wheatley, University of Birmingham, Birmingham; Ian Lewis, Leeds Community Healthcare National Health Service Trust, Leeds; Alan Craft, Newcastle University, Newcastle upon Tyne, United Kingdom; Marie-Cecile Le Deley and Cyril Lervat, Centre Oscar Lambret, Lille; Gwénaël Le Teuff, Nathalie Gaspar, and Odile Oberlin, Institut Gustave Roussy, Villejuif; Jean-Yves Blay, Centre Léon Bérard; Perrine Marec-Berard, Institute of Pediatric Onco-Haematology, Lyon; Marie-Pierre Castex, Centre Hospitalier Universitaire de Toulouse, Toulouse; Jean-Claude Gentet, Centre Hospitalier Universitaire La Timone, Marseille; Marta Jimenez, Unicancer; Valerie Laurence and Jean Michon, Institut Curie, Paris; France; Uta Dirksen, Sebastian Bauer, Andreas Ranft, University Hospital Essen, Essen; Susanne Amler, Institut für Biometrie und Klinische Forschung; Wolfgang Hartmann and Heribert Juergens, Universitätsklinikum, Münster, Münster; Stefan Bielack, Klinikum Stuttgart, Stuttgart; Stefan Burdach, Comprehensive Cancer Center, München; Dagmar Dilloo, University-Clinic Bonn, Bonn; Angelika Eggert, Charité University; Peter Reichardt, HELIOS Klinikum Berlin-Buch, Berlin; Wolf-Achim Hassenpflug, University Medical Center Hamburg-Eppendorf, Hamburg; Thomas Klingebiel, Childrens University Hospital, Frankfurt; Udo Kontny, University Medical Center Aachen, Aachen; Michael Paulussen, Children's and Adolescents' Hospital, Datteln; Germany; Douglas S. Hawkins, Seattle Children's Hospital, Seattle, WA; Hans Gelderblom, Leiden University Medical Center, Leiden; Hendrik van den Berg, University of Amsterdam, Amsterdam, the Netherlands; Lars Hjorth, Skane University Hospital, Lund, Sweden; Jarmila Kruseova, Faculty Hospital Motol Prague, Prague, Czech Republic; Ruth Ladenstein, St Anna Children's Hospital and Children's Cancer Research Institute, Vienna, Austria; Sandrine Marreaud, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.2516
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.2516DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209090PMC
September 2018

The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact.

Histopathology 2018 Aug 24;73(2):197-206. Epub 2018 Mar 24.

Department of Surgery, Leiden University Medical Centre, Leiden, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13489DOI Listing
August 2018

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer.

Br J Cancer 2018 07 14;119(2):164-169. Epub 2018 May 14.

Department of Surgery, Leiden University Medical Centre, Albinusdreef 2, 2300 RC, Leiden, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0083-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048031PMC
July 2018

Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma.

Clin Cancer Res 2018 06 6;24(11):2678-2687. Epub 2018 Mar 6.

Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-3512DOI Listing
June 2018

Rapid Viral Diagnosis of Orthopoxviruses by Electron Microscopy: Optional or a Must?

Viruses 2018 03 22;10(4). Epub 2018 Mar 22.

(ret) University of Newcastle upon Tyne, Burnfoot, Stocksfield, Northumberland, NE43 7TN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/v10040142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923436PMC
March 2018

Early Evaluation of Response Using F-FDG PET Influences Management in Gastrointestinal Stromal Tumor Patients Treated with Neoadjuvant Imatinib.

J Nucl Med 2018 02 28;59(2):194-196. Epub 2017 Sep 28.

Department of Medical Oncology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.117.196642DOI Listing
February 2018

Perioperative Management of Extremity Soft Tissue Sarcomas.

J Clin Oncol 2018 01 8;36(2):118-124. Epub 2017 Dec 8.

Rick L. Haas, The Netherlands Cancer Institute, Amsterdam; Rick L. Haas, Michiel A.J. van de Sande, and Hans Gelderblom, Leiden University Medical Centre, Leiden, the Netherlands; Alessandro Gronchi, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy; Elizabeth H. Baldini, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA; Christina Messiou, The Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom; Eva Wardelmann, University Hospital Münster, Münster, Germany; Axel Le Cesne, Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.74.7527
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.74.7527DOI Listing
January 2018

Are pathological high-risk features in locally advanced rectal cancer a useful selection tool for adjuvant chemotherapy?

Eur J Cancer 2018 01 7;89:1-8. Epub 2017 Dec 7.

Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.11.006DOI Listing
January 2018

A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report.

BMC Cancer 2018 01 22;18(1):92. Epub 2018 Jan 22.

Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-3999-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778698PMC
January 2018

Elderly patients with gastrointestinal stromal tumour (GIST) receive less treatment irrespective of performance score or comorbidity - A retrospective multicentre study in a large cohort of GIST patients.

Eur J Cancer 2017 11 23;86:318-325. Epub 2017 Oct 23.

Netherlands Cancer Institute / Antoni van Leeuwenhoek Hospital, Department of Medical Oncology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.09.017DOI Listing
November 2017

Does a glass of Coke boost the exposure to imatinib in gastrointestinal stromal tumour patients after gastrectomy?

Br J Clin Pharmacol 2017 10 4;83(10):2312-2314. Epub 2017 Jul 4.

Department of Pharmacy and Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.13333DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595978PMC
October 2017

The effect of rs5758550 on CYP2D6*2 phenotype and formation of endoxifen in breast cancer patients using tamoxifen.

Pharmacogenomics 2017 Aug 26;18(12):1125-1132. Epub 2017 Jul 26.

Leiden Network for Personalised Therapeutics, Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2017-0080DOI Listing
August 2017

Influence of CYP2C8 polymorphisms on imatinib steady-state trough level in chronic myeloid leukemia and gastrointestinal stromal tumor patients.

Pharmacogenet Genomics 2017 06;27(6):223-226

Departments of aMedical Oncology bClinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden cCentral Hospital Pharmacy dDepartment of Hospital Pharmacy eDepartment of Hematology, Haga Teaching Hospital, The Hague fDepartment of Epidemiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam gHospital Pharmacy hDepartment of Internal Medicine, Reinier de Graaf Group, Delft, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000278DOI Listing
June 2017

Evaluation of KDR rs34231037 as a predictor of sunitinib efficacy in patients with metastatic renal cell carcinoma.

Pharmacogenet Genomics 2017 06;27(6):227-231

aHereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO) bOncology Department, Hospital Universitario 12 de Octubre cSpanish Oncology Genitourinary Group (SOGUG) dISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Madrid, Spain eDepartment of Clinical Pharmacy and Toxicology fDepartment of Medical Oncology gDepartment of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden hDepartment of Medical Oncology, VU University Medical Center, Amsterdam iDepartment of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands jDepartment of Solid Tumour Oncology, Cleveland Clinic Foundation (CCF) Taussig Cancer Institute, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000280DOI Listing
June 2017

Limb Amputation after Multiple Treatments of Tenosynovial Giant Cell Tumour: Series of 4 Dutch Cases.

Case Rep Orthop 2017 28;2017:7402570. Epub 2017 Jun 28.

Orthopaedic Surgery, Leiden University Medical Center, Leiden, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/7402570DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506462PMC
June 2017

Clinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patients.

Eur J Cancer 2017 05 8;76:76-83. Epub 2017 Mar 8.

Netherlands Cancer Institute - Antoni van Leeuwenhoek, Department of Medical Oncology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.02.007DOI Listing
May 2017

Influenza vaccination in adult patients with solid tumours treated with chemotherapy.

Eur J Cancer 2017 05 17;76:134-143. Epub 2017 Mar 17.

Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.02.012DOI Listing
May 2017

Giant cell tumour of bone in the denosumab era.

Eur J Cancer 2017 05 30;77:75-83. Epub 2017 Mar 30.

Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.02.021DOI Listing
May 2017

Evaluation of Quality of Life at Progression in Patients with Soft Tissue Sarcoma.

Sarcoma 2017 23;2017:2372135. Epub 2017 Apr 23.

Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/2372135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420413PMC
April 2017

A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review.

Expert Rev Mol Diagn 2016 17;16(5):605-18. Epub 2016 Feb 17.

a Department of Clinical Pharmacy and Toxicology , Leiden University Medical Center , Leiden , Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737159.2016.1148601DOI Listing
December 2016

Efficacy of pazopanib and sunitinib in advanced axial chordoma: a single reference centre case series.

Clin Sarcoma Res 2016 1;6:19. Epub 2016 Nov 1.

Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13569-016-0059-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088663PMC
November 2016

Panobinostat-A Potential Treatment for Metastasized Ewing Sarcoma? A Case Report.

Pediatr Blood Cancer 2016 10 1;63(10):1840-3. Epub 2016 Jun 1.

Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26077DOI Listing
October 2016

HLA-G and classical HLA class I expression in primary colorectal cancer and associated liver metastases.

Hum Immunol 2016 Sep 8;77(9):773-9. Epub 2016 Mar 8.

Dept. of Surgery, Leiden University Medical Center, Leiden, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humimm.2016.03.001DOI Listing
September 2016

Promoter methylation and mRNA expression of HLA-G in relation to HLA-G protein expression in colorectal cancer.

Hum Immunol 2016 Sep 28;77(9):764-72. Epub 2016 May 28.

Dept. of Surgery, Leiden University Medical Center, Leiden, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humimm.2016.05.023DOI Listing
September 2016

Molecular oncogenesis of chondrosarcoma: impact for targeted treatment.

Curr Opin Oncol 2016 07;28(4):314-22

aDepartment of Clinical Oncology bDepartment of Pathology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000300DOI Listing
July 2016

Ebola virus disease: any risk for oral and maxillo-facial surgery? An overview.

Oral Maxillofac Surg 2016 Jun 19;20(2):111-4. Epub 2016 Jan 19.

Department of Oral Medicine, Dental Radiology and Oral Surgery, CC3, Charité, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10006-015-0542-1DOI Listing
June 2016

Tissue factor associates with survival and regulates tumour progression in osteosarcoma.

Thromb Haemost 2016 05 14;115(5):1025-33. Epub 2016 Jan 14.

Henri H. Versteeg, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands, Tel.: +31 715263872, Fax: +31 71526755, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH15-07-0541DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428546PMC
May 2016

Replication of a genetic variant in ACYP2 associated with cisplatin-induced hearing loss in patients with osteosarcoma.

Pharmacogenet Genomics 2016 May;26(5):243-7

aLaboratory of Pediatric Oncology bDepartment of Pediatric Hematology and Oncology, Department of Pediatrics Departments of cHuman Genetics dMedical Oncology, Radboud university medical center, Nijmegen Departments of eClinical Pharmacy & Toxicology fMedical Oncology, Leiden University Medical Center, Leiden gDepartment of Pediatric Hematology and Oncology, University Medical Center Groningen, Groningen hDepartment of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000212DOI Listing
May 2016

Evaluation of clinical implementation of prospective DPYD genotyping in 5-fluorouracil- or capecitabine-treated patients.

Pharmacogenomics 2016 05 16;17(7):721-9. Epub 2016 May 16.

Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2016-0013DOI Listing
May 2016

Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: Ready for prime time.

Eur J Cancer 2016 Feb 21;54:40-48. Epub 2015 Dec 21.

Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.11.008DOI Listing
February 2016

Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway.

Eur J Cancer 2016 Jan 5;53:171-80. Epub 2016 Jan 5.

Department of Clinical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.09.009DOI Listing
January 2016